US FDA first approves faecal transplant therapy

The U.S. health regulator on Wednesday approved a faecal transplant-based therapy from Swiss company Ferring Pharmaceuticals to reduce recurrences of bacterial infection, making it the first therapy of its kind to be approved in the United States.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner